September 3, 2019
The Federal Trade Commission has launched an investigation into whether e-cigarette maker Juul Labs used influencers and other marketing tactics to target minors, according to individuals familiar with the effort.
August 28, 2019
North Carolina and its largest private insurer recently have launched initiatives to move away from a fee-for-service model, toward value-based care, and several of the initiatives are showing early signs of success.
The Drug Enforcement Administration on Monday announced that it will move forward with a years-delayed expansion of the agency's marijuana research program, meaning the agency soon could permit more growers to produce marijuana for use in medical studies and other research.
Two experts in a Wall Street Journal opinion piece published last week argued that it is time to abandon biosimilars in favor of leveraging federal price regulation to create more affordable biologic drugs—but the piece drew a rebuttal from former FDA Commissioner Scott Gottlieb, who argued Congress could enact policy changes to make biosmilars more competitive with their biologic counterparts.
American Health Line rounds up the latest health care news in the states.
August 27, 2019
Florida's Agency for Health Care Administration on Wednesday submitted a concept paper to HHS outlining the state's proposal for importing drugs from Canada.
August 26, 2019
Illinois health officials on Friday announced the first death from a severe lung illness that health care providers and officials believe is linked with e-cigarette use and vaping.
Wyoming is preparing a Medicaid waiver request to expand Medicaid coverage for air ambulance rides to all state residents.
August 23, 2019
HHS' Substance Abuse and Mental Health Services Administration on Thursday released a proposed rule intended to make it easier for providers to share the medical records of patients being treated for substance use disorders.
More than one-third of clinical trials that led to the approval of new cancer drugs between 2008 and 2018 did not include data on participants' race, according to a study published last week in JAMA Oncology.
Advisory Board. All rights reserved.